Evidence-Based Hematological Solutions

Similar documents
5/1/2017 DISCUSSION POINTS. Clinical Utility of Immature Cell Indices Beyond the Routine CBC John E. Donnelly BSN, RN

10/15/2015. Clinical Utility of Immature Cell Indices DISCUSSION POINTS HEALTHCARE REFORM PAYMENT MODEL EXPERIMENTS

Nationwide Children s Hospital

Please contact Customer Service with any questions. Ph: option 5

The Value-Driven Laboratory. The Role of the Immature Platelet Fraction (IPF) in the Differential Diagnosis of Thrombocytopenia

The Value-Driven Laboratory. The Role of the Immature Platelet Fraction (IPF) in the Differential Diagnosis of Thrombocytopenia

Combining. and New Diagnostic. to Help Clinicians Achieve. Patient Outcomes at. per Healthcare Encounter

It s Easier Than you Think How to Implement the Advanced Clinical Parameters

Customer Information Literature List Platelets

of s and s Disclosure

May is Better Sleep Month

WHITE PAPER IMMATURE GRANULOCYTE (IG) POPULATIONS MAY IMPROVE THE ASSESSMENT OF INFECTION AND SEPSIS. Getting beyond the flags.

Getting Beyond the Flags: Quantitative assessment of immature granulocyte (IG) populations may improve the assessment of sepsis and inflammation.

The Evolving Role of Reticulated Platelets

3/31/2017 OBJECTIVES CASE STUDY #1 MANUAL REVIEW. Hematology Case Studies: Every Picture Tells a Story

CASE STUDIES PERIPHERAL BLOOD AND BODY FLUIDS

Utilizing Sysmex RET He to Evaluate Anemia in Cancer Patients

LEANING Away Waste and Improving Patient Care with Advances in Hematology

NEW HEMATOLOGY PARAMETERS

IMMATURE PLATELETS CLINICAL USE

Lavender Top Management SUCCESS BEYOND FINANCES

Interpreting the CBC. Robert Miller PA Assistant Professor of Clinical Pediatrics and Family Medicine USC Keck School of Medicine Retired

Lavender Top Management SUCCESS BEYOND FINANCES. Mission/ Vision

Approach to the child with anemia. Nittaya Wisanuyothin,MD. Pediatrics Department, Maharat Nakhonratchasima Hospital

Full Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa

Customer Information Literature List Red Blood Cells

Blutbild 2012: Automatisiert oder manuell? Georg Stüssi Servizio di Ematologia Istituto Oncologico della Svizzera Italiana

Effective Health Care Program

8/28/2015. ACP Toolbox SYSMEX CLINICAL SUPPORT TEAM SYSMEX CUSTOMER RESOURCE CENTER. Maggie Fischer BSN, RN, MS Carolyn Williams, BSN, RN, CRNI

Hematology 101. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD

The importance of thrombocytopenia and its causes

History. n 1865 First description of reticulocytes by Erb, who. n 1881 Using supravital staining, Ehrlich demonstrated

Future Direction of Anemia Management in ESRD. Jay B. Wish, MD 2008 Nephrology Update March 20, 2008

Laboratory diagnosis of iron deficiency: The interpretation of automated counting parameters. Dr Wayne Thomas Derriford Hospital, Plymouth

Evaluation of Anemia. Md. Shafiqul Bari Associate professor (Medicine) SOMC

Advanced parameters offer faster, surer guidance to cancer care

Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss

Journal of Global Pharma Technology

Summary of Recommendation Statements Kidney International Supplements (2012) 2, ; doi: /kisup

American University of Beirut Faculty of Health Sciences Medical Laboratory Sciences Program

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.

Epogen / Procrit. Epogen / Procrit (epoetin alfa) Description

American University of Beirut Faculty of Health Sciences Medical Laboratory Sciences Program

XN-SERIES. Hematology Case Studies: Every Picture Tells a Story

The Role of Reticulocyte Hemoglobin Content (CHr) to Early Diagnosis Iron Deficiency Anemia

Hematology 101. Cindy Rogers, MT(ASCP) Diagnostics System Specialist

INFECTION/ INFLAMMATION

Does Morphology Matter in 2017

XN-SERIES. XN Technology and Case Studies

ANEMIA & HEMODIALYSIS

Customer Information Literature List White Blood Cells

Iron metabolism anemia and beyond. Jacek Lange Perm, 8 October 2016

The Complete Blood Count

K atching Up with KDOQI: Clinical Practice Guidelines & Clinical Practice Recommendations for Anemia of Chronic Kidney Disease 2006

9/23/2018. Hematology Case Studies Jason Anderson, MPH, MT(ASCP) Field Product Specialist OBJECTIVES FLUORESCENT FLOW CYTOMETRY

Changes to CBC Reference Ranges

Literature List Platelets

Interpreting Hematology Scatter-Plots; One Cancer Center s Keys to Seeing the BIG Picture

2. Does the patient have a diagnosis of chronic idiopathic thrombocytopenic purpura (ITP)?

Continuing Education Questions

A Look Into the Determination of Cell Morphology in Hematology in the 21 st Century. Ramon Simon-Lopez, MD Global Scientific Director Beckman Coulter

HAEMATOLOGICAL EVALUATION OF ANEMIA. Sitalakshmi S Professor and Head Department of Clinical Pathology St John s medical College, Bangalore

Challenges in the Laboratory Diagnosis of Anemia

I. Definitions. V. Evaluation A. History B. Physical Exam C. Laboratory evaluation D. Bone marrow examination E. Specialty referrals

XN series. Case interpretation. Gebruikersdag Vlaanderen- 6 oktober 2016

Brief Communication Diagnostic Hematology

Biochemical and Hematological Markers of Inflammation Accurately Predict Sepsis and its Severity in ICU Patients

HEMATOLOGY AND COAGULATION ANALYTIC PROTOCOLS

Pharmacy Prior Authorization

Clinical implications for decreased lymphocytes (lymphopenia) o Corticosteroid therapy, adrenocortical hyperfunction, stress, shock

Guide to the 1-3 Minute Blood Film Microscopic Review: Why and How?

Cbc with differential

Automated Blood Cell Counts. State of the Art. Mauro Buttarello, MD, and Mario Plebani, MD. Abstract

Anemia. A case-based approach. David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017

Use of the XE-2100 in a Patient with Cold Auto-immune Hemolytic Anemia

Faculty of Medicine Dr. Tariq Aladily

Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust

Pharmacy Prior Authorization

Hematology: Challenging Cases with Your Participation COPYRIGHT

Anemia 1: Fourth year Medical Students/ October/21/ 2015/ Abdallah Abbadi.MD.FRCP Professor

Aranesp. Aranesp (darbepoetin alfa) Description

Myelodysplasia/Myeloproliferative Neoplasms (MDS/MPN) Post-HCT Data

Abbott Cell-Dyn Reticulocyte Method Comparison and Reticulocyte Normal Reference Range Evaluation

Research Article Erythrocyte and Reticulocyte Indices on the LH 750 as Potential Markers of Functional Iron Deficiency

New Aspects to Optimize Epoetin Treatment with Intravenous Iron Therapy in Hemodialysis Patients

IRON DEFICIENCY / ANAEMIA ANTHONY BEETON

Acute haemolysis and appearance of PNH-like clones in patients with vitamin B12 deficiency and iron deficiency after iron dextran administration

Anemia in the elderly. Nattiya Teawtrakul MD., PhD

Case scenarios in Pediatric Hematology and Oncology. Dr. Zainul Aabideen Consultant, Pediatric Hematology and Oncology Burjeel Hospital

Update on Chemotherapy- Induced Anemia and Neutropenia Therapies

Clinical use of flow cytometry

NURSE OR PHARMACIST-LED ANEMIA MANAGEMENT PROTOCOL

Sysmex Journal International Vol.9 No.2 (1999)

Comment on European Renal Best Practice Position Statement on Anaemia Management in Chronic Kidney Disease.

Emilia Parodi, 1 Maria Teresa Giraudo, 2 Fulvio Ricceri, 3 Maria Luigia Aurucci, 4 Raffaela Mazzone, 5 and Ugo Ramenghi 4. 1.

Erythropoiesis Stimulating Agents (ESAs): Epoetin Alfa * DIALYSIS *

PNH Glossary of Terms

Performance evaluation of Celltac G: a new automated hematology analyzer

Reticulated platelets as a screening test to identify thrombocytopenia aetiology

AETNA BETTER HEALTH Prior Authorization guideline for Erythropoiesis Stimulating Agents (ESA)

Transcription:

Evidence-Based Hematological Solutions Beyond the Routine CBC Objectives Describe novel hematology parameters and their derivation. Investigate the evidence for their clinical utility. Discuss how new information can be applied to patient care. Explore the operational benefits these parameters provide. Discuss implications for cost of care episode. 1

Escalating Healthcare Pressures Hematological Challenges Infection/Inflammation Response Iron Deficiency Management Thrombopoiesis Management 2

Significance of Left Shift Infection Surveillance 70% of HAI Occur Outside the ICU Klevens, R. M. et al, Public Health Reports, Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002, March April, 2007 Vol. 122: 160 166 3

Pathogenesis of Sepsis Increased neutrophil migration and adhesion Increased coagulation Decreased fibrinolysis Increased inflammation Endothelial injury and loss of barrier integrity Microvascular injury results in altered microcirculatory perfusion Clinical Challenges How soon can we identify a neutrophil response? What is a left shift? How do we ID infection when WBC and ANC are normal? 4

Manual WBC Differential Imprecision The 400-cell diff may be acceptable for relatively high counts, it is not suitable for counts of less than 5% 2 1. Rumke CL: The statistically expected variability in differential leukocyte counting. p. 39. In Koepke JA (ed): Differential Leukocyte Counting. College of American Pathologists, Skokie, IL 1978, with permission. 2. Fernandes (2007) AJCP 128:454-463 Sooner or Later? 11% * * 5.5% 5% 4.5% * * * * * * * * * * * * * 1.0% * * * 5

Automated 6-Part Differential IG% and IG# IG Precision Fernandes and Hamaguchi (2007). Am J Clin Pathol;128:454-463 6

IG Correlation Studies Fernandes and Hamaguchi (2007). Am J Clin Pathol;128:454-463 IG: Better than WBC Figure 1. ROC curves comparing ability of IG (blue), ANC (green), and WBC count (red) to predict infection. The IG and ANC curves are superimposable. Ansari-Lari, et al (2003). Am J Clin Pathol; 120:795-799 7

WBC vs. IG as Predictors of Sepsis Prediction of infections or bacteremia might be improved by adding IG into an algorithm with other lab parameters to target a careful workup of a subset of patients. Ansari-Lari, et al (2003). Am J Clin Pathol; 120:795-799 IG: Elevated When Other Markers are Not Briggs, C. et al (2003). Laboratory Hematology;117-123 8

IG: Elevated When Other Markers are Not IG can elevate in infection even when WBC, ANC, and other markers are normal Briggs, C. et al (2003). Laboratory Hematology;117-123 Clinical Utility: Automated Immature Granulocyte Count Briggs concludes, IG count can highlight a potential acute infectious inflammatory response at a relatively early state... when other blood count parameters are in the overall normal range and are generally nonspecific indicators. (Discussion) Briggs, C. et al (2003). Laboratory Hematology;117-123 9

Summary: Automated IG Count More precise than 100-cell diff (Fernandes). Good correlation with flow (Fernandes). Better sensitivity and specificity than WBC alone in predicting infection in patients admitted through the ED with suspected bactermia (Ansari-Lari). 92% PPV in patients with positive blood cultures and IG >3% (Ansari-Lari). IG can elevate in infection/inflammation even when the WBC and other markers are not elevated (Briggs). IG, a direct cellular measure of leukopoiesis, may aid the ability to detect infection if added to current protocols Anemia Management 10

Anemia Prevalence Prevalence of Anemia 3.4 million people in US 2 billion people globally 30% of world s population Many of these anemias are due to iron deficiency (ID) In children, ID may adversely affect neurodevelopment and behavior and the effects may be irreversible National Anemia Action Council Patients at Highest Risk of Anemia 11

Traditional Lab Anemia Work-up Hgb less than 12g/dL MCV less than 80 fl Microcytic / Hypochromic RBC RDW-SD & RDW-CV Increased (measures of ansiocytosis) Reticulocytes Decreased Finding Balance in Anemia Management Challenge How do you balance dosage and timing of iron therapy? What is the best assessment to balance ESA and Iron therapy? What is the best assessment of iron stores? 12

Serum Iron Studies Iron Metabolism If we want to know about iron metabolism at the cellular level... Shouldn t we directly measure changes to developing RBC? 13

Reticulocyte Method Reticulocyte Parameters Reticulocytes # and % of immature RBC s Immature Reticulocyte Fraction Newly released from the marrow, a direct cellular measurement of erythropoiesis Reticulocyte Hemoglobin Direct cellular measure of iron availability 14

Anemia Assessment d Onofrio, Zini, Rowan, 2002 Reticulocyte Hemoglobin RET-He / CHr Measured at cellular level Monitor acute changes in hemoglobin incorporation into the erythron More sensitive than indirect chemical measurements Detect non-responders to ESA (Functional Iron Deficiency) 15

Precision Analysis Clinical Laboratory Hematology. 2006 Oct; 28(5):303-308. Reticulocyte Hemoglobin Equivalent (Ret He) and Assessment of Iron-deficient States. Brugnara, C., Schiller, B., Moran, J. Reticulocyte Hemoglobin Comparison Clinical Laboratory Hematology. 2006 Oct; 28(5):303-308. Reticulocyte Hemoglobin Equivalent (Ret He) and Assessment of Iron-deficient States. Brugnara, C., Schiller, B., Moran, J. 16

Screening Children for Iron Deficiency... Screening for anemia with a Hb determination neither identifies children with ID nor specifically identifies those with IDA. Pediatrics. 2010;126;1040-1050. Diagnosis and Prevention of Iron Deficiency and Iron- Deficiency Anemia in and Infants and Young Children (0-3 Years of Age). Baker, R., Greer, F. and The Committee on Nutrition. Screening Children for Iron Deficiency Pediatrics. 2010;126;1040-1050. Diagnosis and Prevention of Iron Deficiency and Iron- Deficiency Anemia in and Infants and Young Children (0-3 Years of Age). Baker, R., Greer, F. and The Committee on Nutrition. 17

Recommendations for Screening A low CHr concentration has been shown to be the strongest predictor of ID in children. For infants with Hb <11.0 mg/dl or with significant risk of ID or IDA, SF and CRP or CHr levels should also be measured to increase the sensitivity and specificity of the diagnosis. Pediatrics. 2010;126;1040-1050. Diagnosis and Prevention of Iron Deficiency and Iron- Deficiency Anemia in and Infants and Young Children (0-3 Years of Age). Baker, R., Greer, F. and The Committee on Nutrition. RET-He in the Diagnosis of IDA Diagnostic performance of RET-He is excellent compared to traditional parameters 27.2 pg 93.3% 83.2% * <40 <20 <100 <11 * For patients on maintenance hemodialysis Clinical Laboratory Hematology. 2006 Oct; 28(5):303-308. Reticulocyte Hemoglobin Equivalent (Ret He) and Assessment of Iron-deficient States. Brugnara, C., Schiller, B., Moran, J. 18

KDOQI Guidelines for Evaluation of Anemia Initial Anemia Evaluation Cellular Assessment Hgb < 12 g/dl RBC indices Absolute Retic WBC & Diff Platelet Iron Assessment Serum ferritin Serum TSAT or CHr Iron Assessment Indices HD-CKD Target Ferritin > 200 ng/ml and Tsat > 20% or CHr > 29 pg/cell National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis 47:S1-S146, 2006 (suppl 3). Variations in Tests of Anemia and Iron Status Hb, Hct, and RET-He, but not TSAT or Ferritin, are useful analytes to guide dose adjustment for ESA or IV iron. Am J Kidney Dis. 2010 Sep;56(3):540-6. Analytical and Biological Variation in Measures of Anemia and Iron Status in Patients Treated With Maintenance Hemodialysis. Van Wyck, D., Alcorn H., Gupta, R. Epub 2010 Jul 16. 19

Variations in Tests of Anemia and Iron Status Am J Kidney Dis. 2010 Sep;56(3):540-6. Analytical and Biological Variation in Measures of Anemia and Iron Status in Patients Treated With Maintenance Hemodialysis. Van Wyck, D., Alcorn H., Gupta, R. Epub 2010 Jul 16. Utility of RET-He for ID The presence of inflammation and uremia makes this diagnosis particularly challenging for dialysis patients. By directly measuring the RET-He, early stages of iron deficiency may be identified, at a time that other traditional biochemical parameters are non-informative. Clinical Laboratory Hematology. 2006 Oct; 28(5):303-308. Reticulocyte Hemoglobin Equivalent (Ret He) and Assessment of Iron-deficient States. Brugnara, C., Schiller, B., Moran, J. 20

Pathway to Identify and Evaluate Anemia* *in elective surgical patients Anesth Analg. 2005;101:1858-1861. Goodnough, L T. et al. Fig. 1 Early Identification for Appropriate Intervention The course of 2 clinical parameters during preoperative epoetin treatment... There is a clear difference between responders and nonresponders. The haemoglobinisation level of reticulocytes is an early detector of functional iron deficiency due to epoetin injections. Sysmex Journal International. 2009; 19:1, 1-8. Protocol for Transfusion Free Major Orthopaedic Operations Using RET-He. Muusze, R. et al. adapted from the original in Dutch Kwaliteitsingtituut voor de gezondheidszorg CBO. Richtlijn Bloedtransfusie. Utrecth/Alphen a/d Rinin, 2004with kind permission from the publisher.. 21

Outcomes with Faster Identification of Non-responders RET-He identified non-responders more quickly, allowing faster hemoglobin recovery in severe anemia, greater efficiency in OR scheduling, better transfusion management, and faster post surgical recovery of blood loss. Sysmex Journal International. 2009; 19:1, 1-8. Protocol for Transfusion Free Major Orthopaedic Operations Using RET-He. Muusze, R. et al. Decrease in Blood Transfusions Fig. 3. Blood transfusion orthopaedic recovery plan 2001-2008. Sysmex Journal International. 2009; 19:1, 1-8. Protocol for Transfusion Free Major Orthopaedic Operations Using RET-He. Muusze, R. et al. 22

Summary: Reticulocyte Hemoglobin More comprehensive workup of patients with suspected IDA Direct cellular measurement for faster indication of patient response Less variation than acute phase reactants May improve care of patients on ESA / IV Iron therapy when used with other information Manage cost of care for severe iron deficiency and iron deficiency anemia Thrombopoiesis Management 23

Clinical Challenge in Thrombocytopenia What is the cause of the thrombocytopenia? Is this a disorder of decreased production? Is platelet destruction increased? Might this patient have HIT? Should we withhold ARV? Is patient s bone marrow recovering adequately without intervention? Will we need to consider platelet transfusions? Platelet Transfusions 10 million platelet units are given to 2.2 million recipients each year 1:2,000 platelet units may be contaminated with bacteria 1:20,000 recipients die from transfusion-transmitted sepsis 2nd highest rate of transfusion-related death Alloimmunization Product Availability 24

What about PLT Transfusions? Comprehensive Platelet Count Immature Platelet Fraction (Reticulated Platelets) Platelets newly released from the bone marrow % of total platelets that are immature Indicates thrombopoiesis Plts IPF = Production Plts IPF = Destruction 25

Immature Platelet Fraction Fluorescent dye binds to platelet granules and RNA Immature platelets fluoresce more than mature platelets IPF is a direct cellular measurement of thrombopoiesis. Reference Range is 1.1 6.1% British Journal of Hematology. 2004 126.93 99. Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Briggs, C, Kunka, S. Hart, D. Oguni, S. Machin, S. Immature Platelet Fraction Accuracy Am J Clin Pathol 2006;125:282-287. A Clinical Evaluation of High Fluorescent Platelet Fraction Percentage in Thrombocytopenia. Kickler, T., Oguni, S, Borowitz, M. 26

Differentiate Physiological Mechanisms Low PLT + Low IPF Consistent with production disorder Normal British Journal of Hematology. 2004, 126.93 99. Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Briggs, C, Kunka, S. Hart, D. Oguni, S. Machin, S. Transfusion Medicine. 2006, 16, 101 109. Immature platelet fraction measurement: a future guide to platelet transfusion requirement after haematopoietic stem cell transplantation. Briggs, C., Hart, D., Kunka, S., Oguni, S., Machin, S. Low PLT+ High IPF Consistent with destruction mechanism (ITP, TTP, DIC, autoimmune) Immature Platelet Fraction for Differential Diagnosis In thrombocytopenia, does IPF help differentiate between consumptive and aplastic causes? In thrombocytopenia, does regular monitoring of IPF provide valuable information for treatment decisions? British Journal of Hematology. 2004 126.93 99. Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Briggs, C, Kunka, S. Hart, D. Oguni, S. Machin, S. 27

Immature Platelet Fraction for Transfusion Management Fig. 2 IPF should allow a more controlled prophylactic platelet transfusion policy to be implemented at specified threshold count, particularly when platelet recovery is imminent. Transfusion Medicine. 2006, 16, 101 109. Immature platelet fraction measurement: a future guide to platelet transfusion requirement after haematopoietic stem cell transplantation. Briggs, C., Hart, D., Kunka, S., Oguni, S., Machin, S. Clinical Utility: Transfusion Management Predicting platelet recovery would permit more reasoned use of prophylactic platelet transfusion and provide the potential to reduce the use of platelet concentrates, minimizing possible transfusion-transmitted infections. Transfusion Medicine. 2006, 16, 101 109. Immature platelet fraction measurement: a future guide to platelet transfusion requirement after haematopoietic stem cell transplantation. Briggs, C., Hart, D., Kunka, S., Oguni, S., Machin, S. 28

Immature Platelet Fraction to Assess Bone Marrow Recovery How well can IPF predict platelet recovery following peripheral blood HPC transplantation? Laboratory Hematology, 2006 12:125 130. Immature Platelet Fraction as a Predictor of Platelet Recovery Following Hematopoietic Progenitor Cell Transplantation. Zucker, M. et al. Clinical Utility: Bone Marrow Recovery Following HPC transplantation, IPF recovered significantly earlier than platelet count, ANC, and IRF. A persistently low IPF in this setting would suggest failure of thrombopoietic recovery. Zucker, M. Laboratory Hematology, 12:125-130 29

Summary: Immature Platelet Fraction Provides a direct cellular measurement of thrombopoietic activity May assist in determining cause/differential diagnosis of thrombocytopenia when used with patient information and platelet count May provide more information for prophylactic platelet transfusion management, rather than using platelet trigger alone. Beyond the Routine CBC Thank You 30